Tiziana Life Sciences TLSA Stock
Tiziana Life Sciences Price Chart
Tiziana Life Sciences TLSA Financial and Trading Overview
| Tiziana Life Sciences stock price | 1.16 USD |
| Previous Close | 1.16 USD |
| Open | 1.19 USD |
| Bid | 1.1 USD x 100 |
| Ask | 1.18 USD x 300 |
| Day's Range | 1.09 - 1.19 USD |
| 52 Week Range | 1.04 - 2.6 USD |
| Volume | 146.77K USD |
| Avg. Volume | 210.18K USD |
| Market Cap | 146.35M USD |
| Beta (5Y Monthly) | 0.424 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.16 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.89 USD |
TLSA Valuation Measures
| Enterprise Value | 135.03M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.760962 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 14.935064 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.393 |
Trading Information
Tiziana Life Sciences Stock Price History
| Beta (5Y Monthly) | 0.424 |
| 52-Week Change | -27.21% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 2.6 USD |
| 52 Week Low | 1.04 USD |
| 50-Day Moving Average | 1.32 USD |
| 200-Day Moving Average | 1.55 USD |
TLSA Share Statistics
| Avg. Volume (3 month) | 210.18K USD |
| Avg. Daily Volume (10-Days) | 225.06K USD |
| Shares Outstanding | 127.26M |
| Float | 64M |
| Short Ratio | 6.18 |
| % Held by Insiders | 43.47% |
| % Held by Institutions | 2.94% |
| Shares Short | 1.46M |
| Short % of Float | 4.01% |
| Short % of Shares Outstanding | 1.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2499:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -115.96% |
| Return on Equity (ttm) | -924.32% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -21120000 USD |
| Net Income Avi to Common (ttm) | -18431000 USD |
| Diluted EPS (ttm) | -0.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.01M USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 456K USD |
| Total Debt/Equity (mrq) | 876.92 USD |
| Current Ratio (mrq) | 0.763 |
| Book Value Per Share (mrq) | 0.077 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12847000 USD |
| Levered Free Cash Flow (ttm) | -5476750 USD |
Profile of Tiziana Life Sciences
| Country | United States |
| State | N/A |
| City | London |
| Address | 14/15 Conduit Street |
| ZIP | W1S 2XJ |
| Phone | 44 20 7495 2379 |
| Website | https://www.tizianalifesciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Q&A For Tiziana Life Sciences Stock
What is a current TLSA stock price?
Tiziana Life Sciences TLSA stock price today per share is 1.16 USD.
How to purchase Tiziana Life Sciences stock?
You can buy TLSA shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tiziana Life Sciences?
The stock symbol or ticker of Tiziana Life Sciences is TLSA.
Which industry does the Tiziana Life Sciences company belong to?
The Tiziana Life Sciences industry is Biotechnology.
How many shares does Tiziana Life Sciences have in circulation?
The max supply of Tiziana Life Sciences shares is 127.26M.
What is Tiziana Life Sciences Price to Earnings Ratio (PE Ratio)?
Tiziana Life Sciences PE Ratio is now.
What was Tiziana Life Sciences earnings per share over the trailing 12 months (TTM)?
Tiziana Life Sciences EPS is -0.16 USD over the trailing 12 months.
Which sector does the Tiziana Life Sciences company belong to?
The Tiziana Life Sciences sector is Healthcare.
Tiziana Life Sciences TLSA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2310.38 USD — |
-1.07
|
— — | 2287.99 USD — | 2333.46 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}